Middle Molecule Find

Rulebook › V-tags › V329

V329 Label materials and placement

Written V0329 on the CMS-2567 and in QCOR.

Enforces ANSI/AAMI RD47:2002/A1:2003, adopted by reference at 42 CFR 494.50(b)(1) · Appendix H Rev. 246, page 149 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

ANSI/AAMI RD47:2002/A1:2003 Requirements as Adopted by Reference 42 CFR § 494.50(b)(1)

10.2 Label composition

Markings should be resistant to normal reprocessing and dialysis procedures. The dialyzer labeling should not obscure the manufacturer’s model number, lot number, or indicators of the direction of blood or dialysate flow or other pertinent information unless provision is made for recording this information on the label. The label on hemodialyzers with transparent casings should permit the blood path to be readily inspected.

Read 42 CFR 494.50 on the eCFR

CMS's interpretive guidance

Interpretive Guidance § 494.50(b)(1)

AAMI Rationale for the Development and Provisions of this Recommended Practice

A.10.2 Label composition

The AAMI RDD Committee initially recommended using indelible ink to label the dialyzer but changed the recommendation to any method resistant to normal reprocessing and use procedures; other satisfactory materials exist, and requiring indelible ink might preclude some techniques, such as bar coding.

Additional Guidance:

Facility-applied labels must not obscure the pertinent information on the manufacturer’s label and must leave at least a portion of the blood path uncovered to allow visualization of a section of the fibers from header to header.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 149 (the full 469-page PDF) before quoting it.